Ella Instrument- Automated Immunoassay Machine acquisition

The National Institutes of Health, specifically the National Institute of Neurological Disorders and Stroke (NINDS), requires the acquisition of an Ella Immunoassay System to support the Translational Neuroradiology Section (TNS). This automated immunoassay machine is necessary for the immune profiling and biomarker quantification of multiple sclerosis and related neuroinflammatory pathologies. The system enables the reproducible quantification of critical biomarkers, including neurofilament light chain and glial fibrillary acidic protein, using high-throughput, protein-based analysis of serum and plasma samples.

This pre-solicitation notice is categorized under NAICS code 334516, Analytical Laboratory Instrument Manufacturing, and PSC code 6640, Laboratory Equipment and Supplies. There is no set-aside designated for this requirement. The primary place of performance is Bethesda, Maryland, and the solicitation is identified by number 75N98026Q00510. One attachment, a PDF document titled index.pdf, was published with the notice on June 3, 2026.

Responses to this notice are due by June 8, 2026. The point of contact for this acquisition is Vishnuvajjala Hanumanth Rao. The acquisition of the Bio-Techne Ella system is intended to maintain the analytical precision and platform stability required for ongoing investigations into the mechanisms impacting the central nervous system.